|Bid||10.02 x 4000|
|Ask||10.10 x 3200|
|Day's Range||10.01 - 10.10|
|52 Week Range||8.54 - 12.40|
|Beta (3Y Monthly)||1.42|
|PE Ratio (TTM)||8.04|
|Earnings Date||Feb 19, 2020 - Feb 24, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.26|
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) ("Allscripts") today announced the pricing of its previously disclosed private offering of $200 million aggregate principal amount of its 0.875% convertible senior notes due 2027 (the "notes"). Allscripts has also granted the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $30 million aggregate principal amount of the notes. The notes are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering and sale of the notes to the initial purchasers is expected to close on December 9, 2019, subject to customary closing conditions.
Allscripts also expects to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $30 million aggregate principal amount of the notes. The notes will be senior, unsecured obligations of Allscripts, and interest on the notes will be payable semiannually in arrears. Conversions of the notes may be settled in cash, shares of Allscripts’ common stock, or a combination of cash and shares of Allscripts’ common stock, at Allscripts’ election.
EPSi, Allscripts’ (MDRX) flagship budgeting, planning/forecasting, cost accounting and financial decision support platform, announced a new advanced analytics product and services solution to the marketplace. The Advanced Analytics platform provides “out of the box” business intelligence data visualizations that will enable hospital decision makers to analyze current performance, utilizing EPSi’s flexible data model to incorporate a wide range of clinical, financial and operational data. “As EPSi has continued to innovate on our flexible platform, we saw the need to offer new business intelligence capabilities to enable our clients to leverage the rich data in our fully integrated database, which can be further enriched through the use of our Data Extender tool to add even more data to patient records, service lines and more,” said Ralph Keiser, CEO of EPSi.
Anyone researching Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) might want to consider the historical...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Allscripts Healthcare Solutions today announced that San Gorgonio Memorial Hospital selected its electronic health record suite SunriseTM Community Care, which is built specifically for community hospitals.
In its 14th year, the annual RISE Risk Adjustment Forum acts as a resource for health professionals seeking expert knowledge and continuous improvements to risk adjustment programs from experienced industry specialists, including Pulse8, which is part of Veradigm™, an Allscripts (MDRX) business unit. This year’s forum will include Pulse8’s Caralyn Maerz, Director of Provider Engagement, as a panelist to discuss leveling up your provider-health plan relationships on Wednesday, November 13th, from 11:30am - 12:30pm MST at the Fairmont Scottsdale Princess in Scottsdale, Arizona. “I am privileged to be speaking on a panel alongside industry leaders spanning from risk-adjustment experts to provider educators and even medical professors,” stated Caralyn Maerz, Pulse8’s Director of Provider Engagement.
Allscripts (MDRX) third-quarter results gain from growth in bookings and solid segmental performance. Contraction in both gross and operating margins remains a woe.
AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -1.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
CHICAGO-- -- Strong third quarter bookings of $236 million, up 19% year-over-year GAAP EPS ; 6% year-over-year growth in non-GAAP diluted EPS to $0.17 Extended Allscripts Sunrise platform with Northwell Health through 2027 Repurchased $46 million of stock in the third quarter Allscripts Healthcare Solutions, Inc. announced its financial results for the three and nine months ended September 30, 2019. ...
Tamarack Capital Management was founded by Justin John Ferayorni, who remained the fund’s Chief Investment Officer and Portfolio Manager. Mr. Ferayorni holds A.B. degree in Chemistry from Princeton University, as well as Chartered Financial Analyst designation. Prior to founding Tamarack Capital Management, he worked as Healthcare Analyst and Portfolio Manager. He also held a position of […]
AllScripts (MDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AllScripts (MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Time that same day. The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on November 4, 2019. The announcement will also be available at Allscripts investor relations website.
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
Allscripts Healthcare Solutions (MDRX) today announced that Northwell Health has extended its engagement with the comprehensive Allscripts Sunrise inpatient platform through December 2027. Sunrise is currently in use at 19 Northwell hospitals. Northwell Health—New York State’s largest health system, which has been live on Sunrise since 2005—continues to expand the platform’s use as additional Northwell Health facilities come on board.
Veradigm™, an Allscripts (MDRX) business unit dedicated to simplifying healthcare with data-driven health insights and technologies to help manage cost and improve health outcomes, announced today that its Life Sciences business unit joins the Harvard Pilgrim Healthcare Institute and other collaborating partners to continue to develop the FDA Sentinel System, the largest multisite distributed database in the world dedicated to drug safety.